Extended-Spectrum Beta-Lactamases in Clinical Isolates of Klebsiella pneumoniae from Zagreb, Croatia

Journal of Chemotherapy

Volumn 10, Issue 6, 1998, Pages 449-459

  Bedenic, B ^a   Zagar, Z ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Cephalosporins; ESBLs; Extended spectrum beta lactamases; Klebsiella pneumoniae

Indexed keywords

ANTIINFECTIVE AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CONJUGATION; BIOSYNTHESIS; CROATIA; DRUG EFFECT; ENTEROBACTER INFECTION; ESCHERICHIA COLI; GENETICS; HUMAN; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; PLASMID;

ANTI-BACTERIAL AGENTS; CEFTAZIDIME; CEPHALOSPORINS; CONJUGATION, GENETIC; CROATIA; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PLASMIDS;

EID: 0032251670     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.6.449     Document Type: Article

References (27)

1. Petit A, Sirot DL, Chanal CM, et al. Novel plasmid mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrob Agents Chemother 1988; 32: 626-630.
2. Wu SW, Dornbush K, Norgren M, Kronvall G. Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family. J Antimicrob Chemother 1992; 30: 3-16.
3. Legrand P, Fournier G, Bure A, et al. Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals. Eur J Clin Microbiol Infect Dis 1989; 8: 527-529.
4. Vatoupoulos AC, Phillipon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother 1990; 26: 635-648.
5. Katsanis G, Jacoby G. The frequency of extended-spectrum beta-lactamases in isolates of Klebsiella pneumoniae. J Antimicrob Chemother 1992; 29: 345-353.
6. Payne DJ, Amyes SGB. Transferable resistance to extended-spectrum beta-lactams: a major threat or a minor inconvenience? J Antimicrob Chemother 1991; 27: 255-261.
7. Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1991; 35: 1697-1704.
8. Jones RN, Barry AA, Gavan TL, Washington JA. Susceptibility tests: microdilution and macrodilution broth procedures. In: Lennette EH, Ed. Manual of Clinical Microbiology. 4th ed. Washington DC: American Society for Microbiology, 1985: 972-977.
9. Palfreyman JM. Klebsiella serotyping by counter-current immunoelectrophoresis. J Hygiene 1978; 81: 219-225.
10. Power EGM. RAPD typing in microbiology - a technical review. J Hospit Infect 1996; 34: 247-256.
11. Elwell LP, Falkow S. The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian Eds. Antibiotics in Laboratory Medicine. 2nd ed. Baltimore: Williams & Wilkins, 1986: 683-721.
12. Shannon K, King A, Phillips I. Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. J Antimicrob Chemother 1986; 17: 45-50.
13. Perret CJ. Iodometric assay of penicillinase. Nature 1954; 174: 1012-1013.
14. Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acid Res 1979; 7: 1513-23.
15. Stapleton P, Wu P-J, King A, Shannon K, French G, Philips I. Incidence and mechanism of resistance to combination of amoxicillin with clavulanic acid in Escherichia coli. Antimicrob Agents Chemother 1995; 39: 2478-2483.
16. Knothe K, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 35-37.
17. Buisson CB, Legrand P, Philippon A, Montravers F, Ansquer A, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987; 8: 302-306.
18. Sirot D, Sirot J, Labia R, et al. Transferable resistance to third generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother 1987; 20: 323-334.
19. Spencer RC, Wheat PF, Winstanley TG, Cox DM, Plested SJ. Novel beta-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to beta-lactam antibiotics. J Antimicrob Chemother 1987; 20: 919-921.
20. Vuye A, Verschraegen G, Claeys G. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime. Antimicrob Agents Chemother 1989; 33: 757-761.
21. Gutmann I, Ferre B, Goldstein F W, et al. SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad spectrum cephalosporins and monobactams. Antimicrob Agents Chemother 1989; 33: 951-956.
22. Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989; 33: 1451-1456.
23. Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985; 28: 302-307.
24. Casellas JM, Goldberg M. Incidence of strains producing extended spectrum beta-lactamases. Infection 1989; 17(6): 88-90.
25. Podbielski A, Schonling J, Melzer B, Warnatz K, Leutsch HG. Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae. J Gen Microbiol 1991; 137: 569-578.
26. Xiang X, Shannon K, French G. Mechanisms and stability of hyperproduction of the extended-spectrum beta-lactamase SHV-5 in Klebsiella pneumoniae. J Antimicrob Chemother 1997; 40: 525-532.
27. French GL, Shannon KP, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad spectrum cephalosporins and beta-lactam beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase. J Clin Microbiol 1996; 34(2): 358-363.